Diasome

Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, designs and develops insulin-based therapies for the treatment of diabetes in the United States. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; an